Gottlieb says COVID-19 vaccine for kids could be approved by early winter
Washington — Dr. Scott Gottlieb, former head of the Food and Drug Administration and a member of Pfizer's board of directors, predicted Sunday that the drug company's COVID-19 vaccine could be available to children younger than 12 by early winter, a crucial development in the nation's vaccination efforts as kids return to the classrooms.
In an interview with "Face the Nation," Gottlieb said Pfizer will be in a position to file data with the FDA at some point next month, and then submit its application to expand its emergency use authorization for its vaccine in children 5 years and older as early as October.
"The agency will be in a position to make an authorization, I believe, at some point, late fall, probably early winter," Gottlieb told "Face the Nation. "And probably they're going to base their decision on what the circumstances around the country, what the urgency is to get to a vaccine for kids."
The FDA in May authorized Pfizer's two-dose vaccine for emergency use for children ages 12 to 15, and the company has been conducting clinical trials of its COVID-19 shot in children ages 2 and older.
https://www.msn.com/en-us/news/us/gottlieb-says-covid-19-vaccine-for-kids-could-be-approved-by-early-winter/ar-AANRZml
= new reply since forum marked as read
